Evidence map›Paper›PMID 37201798›Full record

SynthesisInternational journal of antimicrobial agents2023

One Health and Global Health View of Antimicrobial Susceptibility through the "Eye" of Aeromonas: Systematic Review and Meta-Analysis.

Daniel Christopher Jones, Emily Lou LaMartina, Jenna Rachel Lewis, Andrew James Dahl, Nischala Nadig, Aniko Szabo, Ryan J Newton, Troy A Skwor

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in International journal of antimicrobial agents, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Pathogens (Basel, Switzerland) · 2025
    Review
  6. Article
  7. Review
  8. Microorganisms · 2025
    Article
  9. Microbiota Dysbiosis inMicroorganisms · 2025
    Article
  10. Aeromonas and Plesiomonas.Microorganisms · 2025
    Article
  11. Journal of water and health · 2025
    Article
  12. Rapid detection of carbapenemase production inJournal of clinical microbiology · 2025
    Article
  13. Article
  14. Susceptibility ofFrontiers in microbiology · 2025
    Article
  15. Review
  16. Article
  17. Pathogens (Basel, Switzerland) · 2024
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Daniel Christopher JonesDepartment of Biomedical Sciences, University of Wisconsin - Milwaukee, Milwaukee, WI, USA.
Emily Lou LaMartinaSchool of Freshwater Sciences, University of Wisconsin - Milwaukee, Milwaukee, WI, USA.
Jenna Rachel LewisDepartment of Biological Sciences, University of Wisconsin - Milwaukee, Milwaukee, WI, USA.
Andrew James DahlDepartment of Biomedical Sciences, University of Wisconsin - Milwaukee, Milwaukee, WI, USA.
Nischala NadigDepartment of Biomedical Sciences, University of Wisconsin - Milwaukee, Milwaukee, WI, USA.
Aniko SzaboDivision of Biostatistics, Institute for Health & Equity, Medical College of Wisconsin, Milwaukee, WI, USA.
Ryan J NewtonSchool of Freshwater Sciences, University of Wisconsin - Milwaukee, Milwaukee, WI, USA.
Troy A SkworDepartment of Biomedical Sciences, University of Wisconsin - Milwaukee, Milwaukee, WI, USA. Electronic address: skwor@uwm.edu.
University of Wisconsin–Milwaukee · USMedical College of Wisconsin · US

Funding

Clinical and Translational Science AwardUL1TR001436 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI FREED, JULIE K · 2015 to 2025
$47.5M
NCATS NIH HHS UL1 TR001436
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is one of the most pressing public health concerns; therefore, it is imperative to advance our understanding of the factors influencing AMR from Global and One Health perspectives. To address this, Aeromonas populations were identified using 16S rRNA gene libraries among human, agriculture, aquaculture, drinking water, surface water, and wastewater samples, supporting its use as indicator bacteria to study AMR. A systematic review and meta-analysis was then performed from Global and One Health perspectives, including data from 221 articles describing 15 891 isolates from 57 countries. The interconnectedness of different environments was evident as minimal differences were identified between sectors among 21 different antimicrobials. However, resistance to critically important antibiotics (aztreonam and cefepime) was significantly higher among wastewater populations compared with clinical isolates. Additionally, isolates from untreated wastewater typically exhibited increased AMR compared with those from treated wastewater. Furthermore, aquaculture was associated with increased AMR to ciprofloxacin and tetracycline compared with wild-caught seafood. Using the World Health Organization AWaRe classifications, countries with lower consumption of "Access" compared to "Watch" drugs from 2000 to 2015 demonstrated higher AMR levels. The current analysis revealed negative correlations between AMR and anthropogenic factors, such as environmental performance indices and socioeconomic standing. Environmental health and sanitation were two of the environmental factors most strongly correlated with AMR. The current analysis highlights the negative impacts of "Watch" drug overconsumption, anthropogenic activity, absence of wastewater infrastructure, and aquaculture on AMR, thus stressing the need for proper infrastructure and global regulations to combat this growing problem.

Indexed as

AeromonasAnti-Infective AgentsOne HealthAnti-Bacterial AgentsDrug Resistance, BacterialGlobal HealthHumansRNA, Ribosomal, 16SWastewaterAnti-Bacterial AgentsAnti-Infective AgentsRNA, Ribosomal, 16SWastewaterAeromonasanthropogenic activityantimicrobial resistanceaquacultureclinicalenvironmental performancewastewater

Identifiers

PMID37201798
PMCPMC10524465
OpenAlexW4376865323

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.